AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) welcomes the passing of the Medicinal Cannabis Legislation Amendment (Securing Patient Access) Bill 2017 (the Bill) in the Senate yesterday.
The Bill was introduced to expand upon the ability of terminally ill patients to access cannabinoid medicines through the Therapeutic Goods Administration (TGA) Special Access Scheme Category A.
Unlike other TGA access schemes which enable doctors to prescribe cannabinoid medicines, under the TGA Special Access Scheme Category A doctors may prescribe to terminally ill patients without waiting for prior approval from the TGA.
For further information please download PDF attached:
Download this document
